Swiss Trauma Registry
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · May 15, 2018
Trial Information
Current as of September 08, 2025
Recruiting
Keywords
ClinConnect Summary
The Swiss Trauma Registry is a clinical trial focused on improving the treatment of patients who have experienced serious injuries, particularly to the head and brain. This project is being conducted in 12 hospitals across Switzerland and aims to create a standard way to collect and analyze data on trauma care. By doing this, the registry hopes to enhance the quality of treatment for critically ill patients and help plan better healthcare services in the future.
To be eligible for the study, participants must have severe injuries, indicated by specific scoring systems that measure injury severity. However, patients who need to be transferred to a burn unit or those who have drowned cannot participate. If someone qualifies, they can expect to be part of a system that monitors their treatment and outcomes over time, contributing to a better understanding of trauma care. This research is important as it can lead to improved treatment methods and ultimately better recovery for trauma patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • injury severity code \> 16 and 7 or abbreviated injury scale \>3 for region of skull and brain
- Exclusion Criteria:
- • patients who will transferred in a burn unit
- • drowned patients
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarau, , Switzerland
Zürich, , Switzerland
Luzern, , Switzerland
Bern, , Switzerland
Lausanne, , Switzerland
Geneva, , Switzerland
Chur, , Switzerland
Basel, , Switzerland
Lugano, , Switzerland
Sion, , Switzerland
St. Gallen, , Switzerland
Winterthur, , Switzerland
Patients applied
Trial Officials
Andreas Marc Müller, Prof MD
Principal Investigator
University Hospital, Basel, Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials